Micropolis AI Robotics美股招股说明书(2026-03-24版)

PROSPECTUS SUPPLEMENT NO. 1(to Prospectus dated January 16, 2026) Micropolis AI RoboticsUp to 7,100,000 Ordinary Shares(for resale) This prospectus supplement (“Prospectus Supplement”) updates and supplements the information contained in the prospectus datedJanuary 16, 2026 (the “Prospectus”), which forms a part of our registration statement on Form F-1 (File No. 333-290424). TheProspectus relates to the resale from time to time by Streeterville Capital, LLC (the “Selling Shareholder”) of ordinary shares ofMicropolis AI Robotics (the “Company,” “Micropolis,” “we,” “us” or “our”) that are issuable upon conversion of a convertiblepromissory note and upon exercise of a warrant originally issued to the Selling Shareholder. Under the Securities Purchase Agreement dated August 21, 2025, we issued to the Selling Shareholder (i) a convertible promissorynote in the original principal amount of 5,430,000 dollars and (ii) a warrant to purchase up to 5,000,000 of our ordinary shares at aninitial exercise price of 5.00 dollars per share, in consideration for gross proceeds of 5,000,000 dollars. The Prospectus covers, amongother things, the resale by the Selling Shareholder of up to 7,100,000 ordinary shares, comprised of both conversion shares issuableunder the note and warrant shares issuable upon exercise of the warrant. This Prospectus Supplement describes recent amendments to the warrant held by the Selling Shareholder and updates the Prospectussolely to reflect those amendments and the corresponding changes to the number of ordinary shares that may be issued upon exerciseof the warrant and offered for resale under the registration statement. Our ordinary shares are listed on the NYSE American under the symbol “MCRP.” On March 23, 2026, the last reported sale price ofour ordinary shares on the NYSE American was $2.91 per share. Investing in our securities involves a high degree of risk. You should carefully read and consider the information set forth under “RiskFactors” beginning on page 14 of the Prospectus, and any risk factors described or incorporated by reference in this ProspectusSupplement, before making any investment decision. Neither the Securities and Exchange Commission (the “SEC”) nor any state securities regulator has approved or disapproved of thesesecurities or passed upon the accuracy or adequacy of this Prospectus Supplement or the Prospectus. Any representation to the contraryis a criminal offense. You should read this Prospectus Supplement together with the Prospectus and any other prospectus supplements or amendments wemay file, as well as the information incorporated by reference in the Prospectus and this Prospectus Supplement. To the extent anyinformation in this Prospectus Supplement is inconsistent with the information contained in the Prospectus or any earlier-filedprospectus supplement, the information in this Prospectus Supplement shall control. The date of this Prospectus Supplement is March 24, 2026. Amendment to Streeterville Warrant On March 23, 2026, we entered into an amendment to the warrant originally issued to the Selling Shareholder (the “WarrantAmendment”). Pursuant to the Warrant Amendment: (i)The maximum number of ordinary shares that may be issued upon exercise of the warrant was reduced from 5,000,000 to2,500,000 (the “Amended Warrant Shares”);(ii) The exercise price of the warrant was reduced from $5.00 per share to $2.75 per share, subject to any adjustmentsprovided for in the warrant as amended; and(iii) The issuance of any conversion shares pursuant to the convertible promissory note issued to the Selling Shareholder shallin no event be a dilutive issuance as defined in the warrant. Except as expressly modified by the Warrant Amendment, the other terms of the warrant, including the exercise period, adjustmentprovisions and other mechanics of exercise, remain unchanged. The Warrant Amendment does not alter the terms of the convertible promissory note issued to the Selling Shareholder, including theinitial conversion price of $2.75 per share, as previously disclosed. Updated Information About the Securities Registered for Resale The registration statement and Prospectus currently relate to the offer and resale by the Selling Shareholder of up to an aggregate of7,100,000 ordinary shares (the “Registrable Securities”), consisting of: (i)ordinary shares issuable upon conversion of the convertible promissory note held by the Selling Shareholder, based onthe note’s initial fixed conversion price; and(ii) up to 5,000,000 ordinary shares originally issuable upon exercise of the warrant at an initial exercise price of 5.00 dollarsper share. As a result of the Warrant Amendment: (i)the maximum number of ordinary shares that may be issued under the warrant has been reduced to 2,500,000; and (ii) the exercise price of the warrant has been decreased to 2.75 dollars per share. Accordingly, from and after the date of this Prospectus Supplement, references in the P